Ga-67 scintigraphy is routinely used to stage and monitor non-Hodgkin's lym
phoma (NHL), It is highly sensitive in high-grade NHL but less so in interm
ediate- and low-grade NHL. Several studies have reported the use of Tl-201
in the low and intermediate grades of NHL and found it superior in tow-grad
e NHL. In this study, the authors evaluated the utility of combined Ga-67 a
nd Tl-201 scintigraphy in low, intermediate, and unusual types of NHL, Comb
ined Tl-201 and Ga-67 scintigraphy were done in 33 patients (18 women, 15 m
en; age range, 21-91 years; mean age, 56 years). Tl-201 and Ga-67 had simil
ar overall patient sensitivity in the 33 patients studied. However, the use
of both agents increased the overall patient sensitivity from 67% (for Ga-
67 only) to 82% and improved the overall site detection from 59 positive si
tes with Ga-67 to 81 abnormal sites with both Tl-201 and Ga-67, The combine
d use of Tl-201 and Ga-67 scintigraphy in low- and intermediate-grade NHL r
esulted in increased disease and site detection and is beneficial for clini
cal follow-up.